Lynne F. McGrath - 22 Mar 2023 Form 4 Insider Report for Alzamend Neuro, Inc. (ALZN)

Role
Director
Signature
/s/ Lynne F. McGrath
Issuer symbol
ALZN
Transactions as of
22 Mar 2023
Net transactions value
+$4,350
Form type
4
Filing time
23 Mar 2023, 16:30:12 UTC
Previous filing
08 Apr 2022
Next filing
16 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALZN Common Stock Purchase $4,350 +10,000 $0.4350 10,000 22 Mar 2023 By Spouse F1
holding ALZN Common Stock 75,000 22 Mar 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were purchased in an individual retirement account owned by Mrs. McGrath's spouse. Mrs. McGrath disclaims beneficial ownership of the shares held by her spouse, and the inclusion of these shares shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.